DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 76 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactEarnings

Vilin Bio Med Limited — Outcome of Board Meeting

NSE 2 hrs ago·15 Sept 2026, 1:02 pm

Vilin BIO MED

Vilin Bio Med Limited has announced the outcome of its board meeting held on September 15, 2026. The company has informed the stock exchanges about the decisions taken during this session. While the specific agenda items discussed remain undisclosed in the public announcement, such meetings are typically used to approve financial results, strategic plans, or significant corporate actions.

For investors, this update serves as a formal confirmation that the company is actively managing its affairs and complying with regulatory disclosure norms. It signals that the board is meeting to review performance and chart future directions. Investors should wait for the official press release to understand the exact nature of the business updates and their potential impact on the company's operations.